Abbildung von einem Gebäude
03 November 2022

GSK Stockmann advises Patrizia on the sale of the office property CO:WK in Munich’s Werksviertel district

GSK Stockmann provided comprehensive advice to Patrizia SE on the sale of the office building CO:WK in Munich’s Werksviertel to the pension fund of Wacker Chemie.

Wacker Chemie’s pension fund (Pensionskasse der Wacker Chemie VVaG) has acquired the project on the MK 7 construction site in Munich’s Werksviertel district for Wacker Chemie AG’s new headquarters. The Werksviertel is a former industrial park which has developed into a trendy and forward-looking neighbourhood in recent years. Patrizia has been the owner of the property since 2019.

The building, designed by the Danish architectural firm C. F. Møller, has more than 18,000 square metres of lettable flexible-use office space over six floors as well as more than 200 underground parking spaces. It is being built to the highest ESG standards (LEED Platinum) and is scheduled to be completed by the end of 2023. The parties have agreed to keep the purchase price confidential.

GSK Stockmann provided comprehensive advice to Patrizia on all legal aspects of the sale with a team led by real estate partner Andreas Eichler. GSK Stockmann previously advised Patrizia on leasing the property to Wacker Chemie AG last year.

Advisers of Patrizia SE:

GSK Stockmann: Andreas Eichler (lead, Real Estate Transactions & Investments), Mark Butt (Public Building & Planning Law), Katrin Reisich (Private Building Law); Associates: Benjamin Scheuber (Real Estate Transactions & Investments), Esther Seibt-Pfitzner, Stephan Wachsmuth (both Tax)

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 02 February 2023

    GSK Update: The new Transparency International Corruption Perceptions Index 2022

    Read more
  • 23 November 2022

    GSK Update: FAQs on the most important PRIIP requirements as of 01.01.2023

    Read more
  • 06 October 2022

    GSK Update: Real estate transfer tax on share deals – how to approach potential double taxation issues

    Read more
Contact person

Dr. Andreas Eichler, LL.M.

Partner*

+49 89 288174-71

andreas.eichler@gsk.de

For reasons of better readability, we use the gender-neutral generic masculine. However, the information expressly refers to all genders.

CO2 Neutral